|
COPYRIGHT 2007 Asia Pulse Pty Ltd
(Full text of a statement. Contact details below.)
SHOT IN THE ARM: SOUTH KOREAN GOVERNMENT PROMISES A HIKE IN DRUG AND PHARMACEUTICAL R&D EXPENDITURE
SINGAPORE--(BUSINESS WIRE)--Sept. 28, 2007--The South Korean healthcare industry could witness tremendous growth in the next five to ten years, as the Government's promise to increase its healthcare as well as drug and pharmaceuticals R&D expenditure will bring in new drug development projects to the country.
New Country Industry Forecasts from the Frost & Sullivan Economic Research and Analytics team addressing the South Korean Healthcare Industry reveal that growth opportunities exist in the areas of healthcare services and consulting, medical tourism, clinical trials, biotechnology, healthcare outsourcing, and medical devices and equipment.
The Government has actively supported and participated in the industry by declaring investor-friendly policies and tax incentives to attract foreign companies. It also encourages health promotion activities and the provision of healthcare services to the poor and vulnerable sections of...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
